Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism α-synuclein inhibitors(Synuclein alpha inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization PharmaKure Ltd.Startup |
Active Organization PharmaKure Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple System Atrophy | Preclinical | GB | PharmaKure Ltd.Startup | 12 Oct 2022 |